| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 03/25/2009 | EP2038276A1 Azolylmethyloxiranes, their use for controlling phytopathogenic fungi and compositions comprising them |
| 03/25/2009 | EP2038272A2 Pyridinonyl pdk1 inhibitors |
| 03/25/2009 | EP2038267A2 Thiadiazolidinone inhibitors of ptpase |
| 03/25/2009 | EP2038266A2 Compounds as cannabinoid receptor ligands and uses thereof |
| 03/25/2009 | EP2038265A2 Human protein tyrosine phosphatase inhibitors and methods of use |
| 03/25/2009 | EP2038264A1 Tetrazole-substituted arylamides |
| 03/25/2009 | EP2038261A2 Pyrazine derivatives with extended conjugation and uses thereof |
| 03/25/2009 | EP2038254A2 Bicyclic compositions and methods for modulating a kinase cascade |
| 03/25/2009 | EP2038253A1 Biphenyl derivatives and their use in treating hepatitis c |
| 03/25/2009 | EP2037915A2 Phenol derivatives for the treatment of respiratory diseases |
| 03/25/2009 | EP2037739A2 Benzyl-substituted quinolone m1 receptor positive allosteric modulators |
| 03/25/2009 | EP1756063A4 Amido compounds and their use as pharmaceuticals |
| 03/25/2009 | EP1718624B1 Benzamide derivatives and their use as glucokinase activating agents |
| 03/25/2009 | EP1636218B1 Thiazolylpiperidine derivatives as mtp inhibitors |
| 03/25/2009 | CN101395153A Use of adenosine A1 and/or dual A1/A2B agonists for production of medicaments for treating diseases |
| 03/25/2009 | CN101395135A New primary amines |
| 03/25/2009 | CN101392174A Soluble electro-green light organic molecule glass material and preparation method and use thereof |
| 03/25/2009 | CN100471856C Bicyclic compounds and compostions as PDF inhibitors |
| 03/25/2009 | CN100471842C Quinolone derivative or its salt |
| 03/25/2009 | CN100471838C VLA-4 inhibitors |
| 03/24/2009 | US7507839 e,g, 1,5-bis(5-acetyl-4,7-dimethoxybenzofuran-6-yloxy)pentane;potassium channel modulator; antiinflammatory agent, autoimmune diseases; immunosuppressant; multiple sclerosis, rejection of foreign organ transplants |
| 03/24/2009 | US7507836 Benzamide modulators of metabotropic glutamate receptors |
| 03/24/2009 | US7507831 Therapy for breast cancer; plant extracts; 4-[(2-benzothiazolyl)thio]-5,7,3',4'-tetra-O-benzyl-epicatechin, 4-[(2-benzothiazolyl)thio]-5,7,3',4'-tetra-O-benzyl-catechin, 4-[(2-benzothiazolyl)thio]-3-O-acetyl-5,7,3',4'-tetra-O-benzyl-epicatechin |
| 03/24/2009 | US7507767 Sulfonamide-containing benzene derivatives which exhibit anti-inflammatory and immunodulatory activity |
| 03/24/2009 | US7507754 e.g. N-{4-[4-(5-Methoxy-pyridin-2-yl)-phenoxymethyl]-5-methyl-furan-2-carbonyl}-2-methyl-benzenesulfonamide; prostaglandin E4 receptor antagonist; analgesic, antiinflammatory agent; migraines and headache |
| 03/24/2009 | US7507741 Heterocyclic compounds |
| 03/24/2009 | US7507420 Peptidyl prodrugs and linkers and stabilizers useful therefor |
| 03/24/2009 | CA2422380C Pyrazole compounds useful as protein kinase inhibitors |
| 03/24/2009 | CA2224060C Manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
| 03/19/2009 | WO2009036068A2 Gambogic amine, a selective trka agonist with neuroprotective activity |
| 03/19/2009 | WO2009035788A1 Alkylsulfonyl-substituted thiazolide compounds |
| 03/19/2009 | WO2009035067A1 Glucocorticoid receptor agonists consisting of 1,3,3-tri- methyl-7-phenyl-3,4-dihydro-1h-quinoxalin-2-one derivatives |
| 03/19/2009 | WO2009034388A1 Compounds for the treatment of metabolic disorders |
| 03/19/2009 | WO2009034133A1 Polymorph forms of (s)-2-((4-benzofuranyl)carbonylaminomethyl)-1-((4-(2-methyl-5-(4-fluorophenyl)thiazolyl)carbonyl)piperidine |
| 03/19/2009 | WO2009034029A2 1-substituted 4-heterocyclylpiperidines for use as cgrp antagonists |
| 03/19/2009 | WO2009015812A3 Prodrugs of 2-amino-6- ( { [2- (4-chlorphenyl) -1, 3-thiaz0l-4-yl] methyl}thio) -4- [4- ( 2 -hydroxyethoxy) phenyl] pyridin-3, 5-dicarbonitrile |
| 03/19/2009 | WO2009014637A3 Heterocyclic amide compounds as protein kinase inhibitors |
| 03/19/2009 | WO2008147626A3 Thiazoles and pyrazoles useful as kinase inhibitors |
| 03/19/2009 | WO2008137619A3 Thiazoles and pyrazoles useful as kinase inhibitors |
| 03/19/2009 | WO2008116107A3 Piperazine derivatives as glucokinase activators |
| 03/19/2009 | US20090076275 Diacylglycerol acyltransferase inhibitors |
| 03/19/2009 | US20090076262 Process for preparing quetiapine and quetiapine fumarate |
| 03/19/2009 | US20090076094 Novel antibacterial compounds |
| 03/19/2009 | US20090076093 Deuterium-enriched rosiglitazone |
| 03/19/2009 | US20090076088 Thrombin Receptor Antagonists |
| 03/19/2009 | US20090076067 Pharmaceutical composition comprising azarhodacyanine compound as active ingredient |
| 03/19/2009 | US20090076063 Carboxamide compound and use of the same |
| 03/19/2009 | US20090076027 Deuterium-enriched lurasidone |
| 03/19/2009 | US20090076025 Deuterium-enriched dasatinib |
| 03/19/2009 | US20090076009 Thiazole derivatives and their use as anti-tumour agents |
| 03/19/2009 | US20090075995 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF |
| 03/19/2009 | US20090075988 phosphodiesterase inhibitors such as 1-[3-(4-fluoro-phenyl-piperazin-1-yl]-6,7-dimethoxy-isoquinoline-4-carbonitrile, having improved solubility, metabolic stability and/or bioavailability, used for the treatment of neurodegenerative diseases, psychological disorders and drug addiction |
| 03/19/2009 | US20090075987 Alkylacetylene substituted acyltryptophanols |
| 03/19/2009 | US20090075986 Anti-inflammatory medicaments |
| 03/19/2009 | US20090075980 Pyrazolopyridines and Analogs Thereof |
| 03/19/2009 | US20090075979 CETP Inhibitors |
| 03/19/2009 | US20090075973 Benzo-fused heterocycles |
| 03/19/2009 | US20090075188 Azo compound, curable composition, color filter, and method of producing the same |
| 03/19/2009 | US20090074373 Optical filter |
| 03/19/2009 | DE102007044032A1 New substituted heteroaryl compounds are hypoxia-inducible factor prolyl-4-hydroxylase inhibitors useful to treat and/or prevent e.g. circulatory heart diseases, heart failure, anemia, chronic kidney diseases and renal failure |
| 03/19/2009 | CA2699472A1 Polymorph forms of (s)-2-((4-benzofuranyl)carbonylaminomethyl)-1-((4-(2-methyl-5-(4-fluorophenyl)thiazolyl)carbonyl)piperidine |
| 03/19/2009 | CA2695517A1 Alkylsulfonyl-substituted thiazolide compounds |
| 03/18/2009 | EP2036954A2 Azo compound, curable composition, color filter, and method of producing the same |
| 03/18/2009 | EP2035413A2 Thiazolyl urea derivatives as phosphatidylinositol 3-kinase inhibitors |
| 03/18/2009 | EP2035409A1 Benzimidazole derivatives which are to be used as anatgonist for the cb1-receptor |
| 03/18/2009 | EP2035375A1 1,3-disubstituted 4-methyl-1h-pyrrole-2-carboxamides and their use for the manufacture of medicaments |
| 03/18/2009 | EP2035372A1 Modulators of the histamine h3-receptor useful for the treatment of disorders related thereto |
| 03/18/2009 | EP2034996A2 Triazole compounds that modulate hsp90 activity |
| 03/18/2009 | EP1567493B1 Phenyl substituted piperidine compounds for use as ppar activators |
| 03/18/2009 | EP1539151B1 Biaryl compounds having anti-infective activity |
| 03/18/2009 | EP1453810B1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same |
| 03/18/2009 | EP1386912B1 Cyclic amidine derivative |
| 03/18/2009 | EP0963984B1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics |
| 03/18/2009 | CN101389622A Pyrimidine derivatives used as pi-3 kinase inhibitors |
| 03/18/2009 | CN101389619A Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof |
| 03/18/2009 | CN101389613A Macrocyclic factor viia inhibitors useful as anticoagulants |
| 03/18/2009 | CN101386620A Thiazole derivative and preparation method and application thereof |
| 03/18/2009 | CN100469777C Preparation process of aztreonam |
| 03/18/2009 | CN100469770C 5-substituted-pyrazine or -pyridine glucokinase activators |
| 03/18/2009 | CN100469767C Bipiperidinyl-derivatives and their use as chemokine receptor inhibitors |
| 03/17/2009 | US7504513 e.g. 2-(5,6-Dimethoxy-benzoimidazol-1-yl)-4-phenyl-thiazole-5-carboxylic acid; Polo-like kinase 1 inhibitor; antiproliferative, anticarcinogenic, antitumor agent; solid tumors of various origins (breast, lung, colon, stomach, ovary, smooth muscle, and esophagus) and in non-Hodgkin lymphomas |
| 03/17/2009 | US7504512 BCL-X1 protein inhibitors; anticarcinogenic agents |
| 03/17/2009 | US7504511 e.g. N-[4-(5-Butyl-2-methoxyphenyl)-1,3-thiazol-2-yl]-4((4-[2-(S)-(hydroxymethyl)pyrrolidin-1-yl]piperidin-1-yl)carbonyl)benzamide; antiinflammatory, anticarcinogenic, antidiabetic, analgesic agent |
| 03/17/2009 | US7504508 PGD2 receptor antagonists for the treatment of inflammatory diseases |
| 03/17/2009 | US7504429 Receptor or non-receptor types; 1H-pyrrole-3-carboxylates; anticarcinogenic, antidiabetic, antiproliferative agents; autoimmune and Crohn's diseases, acromegaly, aging resistance; coadminister tamoxifen, raloxifene, taxol, trastuzumab, tirofiban or a COX-2 inhibitor |
| 03/17/2009 | US7504426 Antiallergens; rhitinis; antiinflammatory agents |
| 03/17/2009 | US7504424 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction |
| 03/17/2009 | US7504423 e.g. 3-((S)-2-amino-2-{trans-4-[4-(5-cyano-2-pyridinyl)-1-piperazinyl]-1-cyclohexyl}acetyl)-1,3-thiazolidine; dipeptidyl-peptidases inhibitor; suppress cleavage of glucagon-like peptides (GLP-1) by inhibition of DPP-IV; antidiabetic agent; obesity, non insulin-dependent diabetes |
| 03/17/2009 | US7504421 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use |
| 03/17/2009 | US7504416 4-substituted quinolines as antitumor agents |
| 03/17/2009 | US7504411 2,3,6-Trisubstituted-4-pyrimidone derivatives |
| 03/17/2009 | US7504410 such as N-[3-[[5-bromo-4-[[3-[[[1-(trifluoromethyl)cyclobutyl]carbonyl]amino]propyl]amino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide; Chks (checkpoint kinases), Akts (protein kinases B) and Pdks (phosphoinositide-dependent kinases) inhibitors; antiproliferative agents |
| 03/17/2009 | US7504402 bicyclo[2.2.2]-oct-1-yl-1,2,4-triazoles; type 2 diabetes, lipid disorders, obesity, atherosclerosis, metabolic syndrome, hyperglycemia, insulin resistance; increase insulin sensitivity in muscle, liver and adipose tissue by correction of the elevated plasma levels of glucose without causing hypoglycemia |
| 03/17/2009 | US7504400 MTP inhibiting aryl piperydines or piperazines substituted with 5-membered heterocycles |
| 03/17/2009 | US7504392 2,3,4,5-tetrahydro-1H-3-benzazepines and their medical use |
| 03/17/2009 | US7504362 Pesticidal compositions |
| 03/17/2009 | US7504162 Heat resistance; forming film |
| 03/17/2009 | CA2340405C Substituted 4-amino-2-aryl-pyrimidines, their production and use and pharmaceutical preparations containing same |
| 03/17/2009 | CA2328234C Compounds that inhibit the binding of integrins to their receptors |
| 03/17/2009 | CA2316351C Benzopyran and benzothiopyran derivatives having retinoid antagonist-like activity |